Safety and efficacy study of lotio
- Conditions
- Healthy female
- Registration Number
- JPRN-UMIN000042289
- Lead Sponsor
- Interface, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 25
Not provided
(1) Subject who is pregnant or nursing, or is planning to become pregnant or nursing during the study; (2)Subject who used any drug, quasi-drug, or supplements, within 1 month before the baseline visit, that will affect the site to be examined; (3) Subject who has a skin disorder such as atopic dermatitis; (4) Subject who will take any skin care medication that may affect the results of the study; (5) Subject who experienced any cosmetic medication that may affect the results of the study; (6) Subject who is currently taking hormone replacement therapy; (7) Subject who is participating in any other clinical trials; and (8) Subject who otherwise disqualified from participation in the study for any reason at the discretion of the study physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method